Relationship Between Anemia and Health Care Costs in Heart Failure

Journal of Cardiac Failure

Volumn 15, Issue 10, 2009, Pages 843-849

  Allen, Larry A ^a   Anstrom, Kevin J ^b   Horton, John R ^b   Shaw, Linda K ^b   Eisenstein, Eric L ^b   Felker, G Michael ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

anemia; costs; Heart failure; resource utilization

Indexed keywords

ACCOUNTING; ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL COST; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RESOURCE ALLOCATION; SCORING SYSTEM; SURVIVAL TIME;

AGED; ANEMIA; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH RESOURCES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 70450221937     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.06.435     Document Type: Article

References (33)

1. Al-Ahmad A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
2. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., and Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
3. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
4. Herzog C.A., Muster H.A., Li S., and Collins A.J. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 10 (2004) 467-472
5. Felker G.M., Shaw L.K., Stough W.G., and O'Connor C.M. Anemia in patients with heart failure and preserved systolic function. Am Heart J 151 (2006) 457-462
6. Anand I.S. Anemia and chronic heart failure: implications and treatment options. J Am Coll Cardiol 52 (2008) 501-511
7. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
8. Ghali J.K., Anand I.S., Abraham W.T., et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 117 (2008) 526-535
9. Okonko D.O., Grzeslo A., Witkowski T., et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51 (2008) 103-112
10. van Veldhuisen D.J., and McMurray J.J. Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 9 (2007) 110-112
11. Lee W.C., Chavez Y.E., Baker T., and Luce B.R. Economic burden of heart failure: a summary of recent literature. Heart Lung 33 (2004) 362-371
12. Berry C., Murdoch D.R., and McMurray J.J. Economics of chronic heart failure. Eur J Heart Fail 3 (2001) 283-291
13. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-171
14. Fang J., Mensah G.A., Croft J.B., and Keenan N.L. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52 (2008) 428-434
15. Solid C.A., Foley R.N., Gilbertson D.T., and Collins A.J. Anemia and cost in Medicare patients with congestive heart failure. Congest Heart Fail 12 (2006) 302-306
16. Nordyke R.J., Kim J.J., Goldberg G.A., et al. Impact of anemia on hospitalization time, charges, and mortality in patients with heart failure. Value Health 7 (2004) 464-471
17. Eisenstein E.L., Shaw L.K., Anstrom K.J., et al. Assessing the clinical and economic burden of coronary artery disease: 1986-1998. Med Care 39 (2001) 824-835
18. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels (1964), Little Brown, Boston, MA
19. National Death Index User's Manual (2003), Department of Vital Statistics, Centers for Disease Control, Hyattsville, MD
20. McCullough P.A., and Lepor N.E. Anemia: a modifiable risk factor for heart disease. Introduction. Rev Cardiovasc Med 6 Suppl 3 (2005) S1-S3
21. Rosenbaum P.R. Model-based direct adjustment. J Am Stat Assoc 82 (1987) 387-394
22. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
23. Bang H., and Tsiatis A. Estimating medical costs with censored data. Biometrika 87 (2000) 329-343
24. Anstrom K., and Tsiatis A. Estimating medical costs with censored data. Biometrics 57 (2001) 1207-1218
25. Gold M.R., Siegel J., Russell L., and Weinstein M. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
26. Thompson S.G., and Barber J.A. How should cost data in pragmatic randomised trials be analysed?. BMJ 320 (2000) 1197-1200
27. Barber J.A., and Thompson S.G. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19 (2000) 3219-3236
28. Weinstein M.C., Siegel J.E., Gold M.R., Kamlet M.S., and Russell L.B. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276 (1996) 1253-1258
29. Liao L., Anstrom K.J., Gottdiener J.S., et al. Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. Am Heart J 153 (2007) 245-252
30. Felker G.M., Gattis W.A., Leimberger J.D., et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 92 (2003) 625-628
31. Go A.S., Yang J., Ackerson L.M., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113 (2006) 2713-2723
32. Liao L., Jollis J.G., Anstrom K.J., et al. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med 166 (2006) 112-118
33. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216